About this event
The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to announce that PMDA will hold the “PMDA-ATC Regenerative Medicines Review Webinar 2021 for NPRA, Malaysia”. The webinar will cover topics relating to the regulation and review process of regenerative medicines, specially focusing on the human somatic cell-processed products and the plasmid vector products, and aims to provide an opportunity for the participants to deepen the knowledge of the regulatory systems by sharing experiences between Malaysia and Japan.
The webinar is offered by the Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA-ATC) in collaboration with the National Pharmaceutical Regulatory Agency (NPRA) and will be held online using the Cisco Webex teleconferencing systems. The webinar is exclusively for regulators working for NPRA, not open to those from other countries/regions, and the training will be provided in English (with consecutive translation in some sessions).
Who should attend
Regulators of NPRA who are currently engaged in the review of regenerative medicines;
- Basic knowledge of the regulations of regenerative medicines review is required.
- All participants are required to actively participate in all of the sessions.
Date / Time
- Friday, March 19 , 2021 10:00 – 12:45 JST (9:00－11:45 MYT)
Program
Contact us
Attention: Registration will be managed by NPRA.
Secretariat, PMDA Asia Training Center
E-mail: PMDA-ATC●pmda.go.jp
Division of Training Center Management
Office of International Programs
Pharmaceuticals and Medical Devices Agency
Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
(Note: For the purpose of security, @ in the e-mail addresses are replaced with ●. Please replace ● with @ when you send an e-mail.)